This article needs to be updated. Please help update this article to reflect recent events or newly available information.(April 2017)
CAPRISA 004 is the name of a clinical trial conducted by CAPRISA. This particular study was the first to show that a topical gel could reduce a person's risk of contracting HIV. The gel used in the study contained a microbicide.
CAPRISA004 is the name of a clinical trial conducted by CAPRISA. This particular study was the first to show that a topical gel could reduce a person's...
states and territories. FHI 360 contributed to a clinical trial called CAPRISA004, which provided an important breakthrough in the fight against HIV and...
mission is to promote HIV prevention and research its epidemiology. CAPRISA004 is the name of a clinical trial testing a microbicide which was experimentally...
diseases epidemiologist and co-founder and Associate Scientific Director of CAPRISA. She is a Professor in Clinical Epidemiology, Columbia University, New...
co-infection, as well as the epidemiology and prevention of Covid-19. The CAPRISA004 tenofovir gel trial, which he co-led with Quarraisha Abdool Karim, provided...
notable research included various clinical trials. The results of the CAPRISA004 trial inspired the research of the MTN and the microbicide field. The...
studied as a topical antiretroviral. One example of a tenofovir study is CAPRISA004 in 2010, finding its use reduced HIV infection risk by 39% overall. Rectal...
acquisition by an estimated 39 percent overall in the CAPRISA (Centre for the AIDS Programme of Research) 004 trial that was conducted in South Africa. In September...
Global Information